Both endothelial and platelet P-selectin also contribute to the maturation of atherosclerotic lesions, and previous studies have demonstrated that lesions where both cell types express P-selectin exhibit a tendency to be more mature than are those where no P-selectin is expressed [61], suggesting that P-selectin presents an attractive potential therapeutic target for atherosclerosis therapies. This evidence concerns the gene SELP and atherosclerosis.